Simplex Trading’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-23,700
| Closed | -$807K | – | 10275 |
|
|
2023
Q3 | $807K | Sell |
23,700
-7,600
| -24% | -$1.14M | ﹤0.01% | 2892 |
|
|
2023
Q2 | $3.19M | Sell |
31,300
-63,000
| -67% | -$5.96M | ﹤0.01% | 1614 |
|
|
2023
Q1 | $8.57M | Buy |
94,300
+81,700
| +648% | +$4.79M | 0.01% | 981 |
|
|
2022
Q4 | $478K | Sell |
12,600
-64,500
| -84% | -$2.22M | ﹤0.01% | 3193 |
|
|
2022
Q3 | $1.94M | Buy |
77,100
+41,800
| +118% | +$1.16M | ﹤0.01% | 1988 |
|
|
2022
Q2 | $1.07M | Sell |
35,300
-33,900
| -49% | -$1.01M | ﹤0.01% | 2540 |
|
|
2022
Q1 | $2.27M | Buy |
69,200
+50,000
| +260% | +$1.48M | ﹤0.01% | 1983 |
|
|
2021
Q4 | $506K | Buy |
19,200
+17,200
| +860% | +$1.33M | ﹤0.01% | 3792 |
|
|
2021
Q3 | $286K | Hold |
2,000
| – | – | ﹤0.01% | 4983 |
|
|
2021
Q2 | $283K | Buy |
2,000
+1,955
| +4,344% | +$221K | ﹤0.01% | 5087 |
|
|
2021
Q1 | $448K | Sell |
45
-56
| -55% | -$6.53K | ﹤0.01% | 3525 |
|
|
2020
Q4 | $1.25M | Buy |
101
+65
| +181% | +$8.54K | ﹤0.01% | 2274 |
|
|
2020
Q3 | $350K | Sell |
36
-28
| -44% | -$3.5K | ﹤0.01% | 3432 |
|
|
2020
Q2 | $998K | Buy |
64
+16
| +33% | +$2.43K | ﹤0.01% | 2155 |
|
|
2020
Q1 | $692K | Sell |
48
-55
| -53% | -$10.6K | ﹤0.01% | 2256 |
|
|
2019
Q4 | $2.1M | Sell |
103
-54
| -34% | -$9.85K | ﹤0.01% | 1434 |
|
|
2019
Q3 | $1.26M | Buy |
157
+131
| +504% | +$11.1K | ﹤0.01% | 1723 |
|
|
2019
Q2 | $245K | Buy |
26
+15
| +136% | +$1.29K | ﹤0.01% | 3266 |
|
|
2019
Q1 | $94K | Buy |
11
+4
| +57% | +$332 | ﹤0.01% | 4401 |
|
|
2018
Q4 | $39K | Sell |
7
-64
| -90% | -$3.91K | ﹤0.01% | 4773 |
|
|
2018
Q3 | $580K | Buy |
71
+27
| +61% | +$1.9K | ﹤0.01% | 2479 |
|
|
2018
Q2 | $153K | Buy |
+44
| New | +$1.34K | ﹤0.01% | 3799 |
|
Simplex Trading's RETA Position: Q3 2023 in Review
Simplex Trading sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 17,884 shares — an estimated $2.69M sold.
Simplex Trading first reported a position in RETA in Q3 2017 and held it in 8 quarters. The position peaked at $1.82M in Q2 2023. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.
- Simplex Trading reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- Simplex Trading sold 17,884 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $2.69M.
- Simplex Trading first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2017 and held it in 8 quarters.
- Simplex Trading's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $1.82M in Q2 2023.
- 2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.
Based on Simplex Trading's 13F filing for Q3 2023, filed 1 Nov 2023.